This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Type 1 Diabetes
and you are
between 15 and 55
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study trials a prototype artificial pancreas system that consists of a Roche insulin pump, a Dexcom continuous glucose monitor (CGM), and an experiential MMPPC (multiple model probabilistic predictive control) algorithm housed on an android cell phone. The system doses insulin based on CGM sensor glucose levels and the experimental algorithm. The aim of this clinical study is to determine the efficacy of the MMPPC controller in adolescents and adults with type 1 diabetes in a hotel setting.

Provided treatments

  • Device: MMPPC algorithm artificial pancreas
Tris trial is registered with FDA with number: NCT02769884. The sponsor of the trial is Rensselaer Polytechnic Institute and it is looking for 10 volunteers for the current phase.
Official trial title:
Multiple Model Probabilistic Predictive Control (MMPPC) Outpatient Clinical Protocol